Compound ID | 2116
Class: Natural product antibiotic
| Spectrum of activity: | Gram-negative |
| Details of activity: | Inhibits fatty acid synthesis by binding to FabB and FabF. Activity against E. coli. |
| Description: | Natural product produced by Streptomyces and Nocardia; total synthesis, several analogues; researched for anticancer treatment |
| Year first mentioned: | 1981 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|